Current Ratio of Aquestive Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aquestive Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Aquestive Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 478%, a 12% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Aquestive Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 478% -64% -12% 30 Sep 2025
Q2 2025 471% +67% +16% 30 Jun 2025
Q1 2025 571% +332% +139% 31 Mar 2025
Q4 2024 610% +472% +343% 31 Dec 2024
Q3 2024 543% +426% +367% 30 Sep 2024
Q2 2024 405% +301% +289% 30 Jun 2024
Q1 2024 239% +126% +111% 31 Mar 2024
Q4 2023 137% +11% +8.9% 31 Dec 2023
Q3 2023 116% -36% -24% 30 Sep 2023
Q2 2023 104% -78% -43% 30 Jun 2023
Q1 2023 113% -90% -44% 31 Mar 2023
Q4 2022 126% -88% -41% 31 Dec 2022
Q3 2022 153% -61% -28% 30 Sep 2022
Q2 2022 182% -26% -12% 30 Jun 2022
Q1 2022 203% -19% -8.4% 31 Mar 2022
Q4 2021 214% -32% -13% 31 Dec 2021
Q3 2021 213% -77% -27% 30 Sep 2021
Q2 2021 208% -84% -29% 30 Jun 2021
Q1 2021 221% -29% -11% 31 Mar 2021
Q4 2020 246% +29% +13% 31 Dec 2020
Q3 2020 290% +97% +50% 30 Sep 2020
Q2 2020 292% +65% +29% 30 Jun 2020
Q1 2020 250% +32% +15% 31 Mar 2020
Q4 2019 217% 31 Dec 2019
Q3 2019 193% 30 Sep 2019
Q2 2019 227% 30 Jun 2019
Q1 2019 218% 31 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.